Clinical Trial

Place-based Cochlear Implant Mapping

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 28, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
The current standard of care approach for programming cochlear implants uses a generalized pitch-map for all patients. This approach fails to account for individualized inner ear anatomy. As a result, many cochlear implant recipients experience place-pitch mismatch. We have recently developed an automated mathematical tool to produce patient-specific, customized cochlear implant pitch-maps (Helpard et al., 2021). In this study, cochlear implant recipients will be randomized to receive either the clinical default pitch-map (the control group) or a place-based pitch-map (the intervention group). Assessments will be conducted at multiple time-intervals to account for patient acclimation and plasticity to both the generalized and individualized pitch-maps. Audiological assessments will be tuned to identify patients' ability to discern pitch scaling and variation in sounds, as well as to understand complexities in speech such as mood and tone. Audiological testing will be conducted in collaboration with the National Centre for Audiology (London, ON) to ensure that the most accurate and relevant metrics are applied.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-09-27; most recent amendment 2025-03-24.
Status change: Not Yet Recruiting → Recruiting 2023-07-11
Trial Details
NCT Number NCT05558514
Lead Sponsor Western University, Canada
Collaborators: Academic Medical Organization of Southwestern Ontario, University of North Carolina, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions Hearing Loss, Sensorineural, Cochlear Implants
Enrollment 30 participants
Start Date 2023-06-07
Primary Completion 2026-05 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2025-03-28